share_log

圣诺医药-B(02257)：王永祥获委任为执行董事

Shengnuo Pharmaceutical-B (02257): Wang Yongxiang was appointed as Executive Director

Zhitong Finance ·  May 10 20:46

Shengnuo Pharmaceutical-B (02257) announced that Dr. Wang Yongxiang was appointed as an executive director from May 1, 2024...

Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) issued an announcement. Dr. Wang Yongxiang was appointed as an executive director with effect from May 10, 2024.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment